Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHA/900904 stock hub

SHA/900904 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/900904is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/900904
In the news

Latest news · SHA/900904

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E77.6
P25 23.5P50 41.3P75 83.2
ROE1.7
P25 -0.9P50 4.1P75 8.8
ROIC3.4
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/900904 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
227
Groups with data
11
Currency
CNY
Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,266
Employees Change
-160%
Employees Change Percent
-11.22
Enterprise value
$2.4B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
CNE0000003X8
Last refreshed
2026-05-10
Market cap
$3B
Price
$0.47
Price currency
USD
Rev Per Employee
1,542,156.65x
Sector
Healthcare
Sic
2834
Symbol
sha/900904
Website
https://www.gzsq.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
1.29%
EV Earnings
63.26x
EV/EBIT
21.84x
EV/EBITDA
12.86x
EV/FCF
26.51x
EV/Sales
1.24x
FCF yield
3.07%
P/B ratio
1.24x
P/E ratio
77.61x
P/S ratio
1.52x
PE Ratio10 Y
48.6x
PE Ratio3 Y
61.08x
PE Ratio5 Y
59.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
5.67%
EBITDA Margin
9.49%
FCF margin
4.67%
Gross margin
45.11%
Gross Profit
$880.7M
Gross Profit Growth
-9.56%
Gross Profit Growth Q
-14.96%
Gross Profit Growth3 Y
-11.33%
Gross Profit Growth5 Y
-3.84%
Net Income
$38.2M
Net Income Growth
-46.43%
Net Income Growth Q
-14.07%
Net Income Growth3 Y
-7.64%
Pretax Margin
3.63%
Profit Margin
1.96%
Profit Per Employee
$30,209
ROA
2.21
Roa5y
1.97
ROCE
4.39
ROE
1.65
Roe5y
2.35
ROIC
3.38
Roic5y
3.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
-10.73%
Cagr15y
-1.64%
Cagr1y
1.69%
Cagr20y
3.43%
Cagr3y
-7.86%
Cagr5y
4.63%
Div CAGR10
8.53%
Div CAGR3
14.17%
Div CAGR5
37.02%
EPS Growth
-46.15
EPS Growth Q
-33.33
EPS Growth3 Y
-8.04
FCF Growth
-46.76%
FCF Growth3 Y
-32.18%
FCF Growth5 Y
100.86%
OCF Growth
-40.1%
OCF Growth10 Y
15.25%
OCF Growth3 Y
-26.94%
OCF Growth5 Y
4.67%
Revenue Growth
-4.71x
Revenue Growth Q
-11.87x
Revenue Growth3 Y
-6.5x
Revenue Growth5 Y
1.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.62
Assets
$3.1B
Cash
$704.5M
Current Assets
$1.6B
Current Liabilities
$605.6M
Debt
$209.5M
Debt EBITDA
$1.11
Debt Equity
$0.09
Debt FCF
$2.3
Equity
$2.4B
Liabilities
$747.6M
Long Term Assets
$1.6B
Long Term Liabilities
$142M
Net Cash
$495M
Net Cash By Market Cap
$16.68
Net Cash Growth
8.08%
Net Debt EBITDA
$-2.67
Net Debt Equity
$-0.21
Net Debt FCF
$-5.42
Tangible Book Value
$2B
Tangible Book Value Per Share
$3.9
WACC
7.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.66
Inventory Turnover
5.03
Net Working Capital
$437.2M
Quick ratio
2.18
Working Capital
$1B
Working Capital Turnover
$1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
0.51%
Dividend Growth
46.56%
Dividend Growth Years
1%
Dividend per share
$0.15
Dividend Years
4
Dividend Yield
32.11%
Ex Div Date
2025-06-05
Last Dividend
$0.15
Payout Frequency
Annual
Payout Ratio
230.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-67.84%
1Y total return
1.69%
200-day SMA
0.52
3Y total return
-21.78%
50-day SMA
0.49
50-day SMA vs 200-day SMA
50under200
5Y total return
25.38%
All Time High
2.77
All Time High Change
-82.06%
All Time High Date
1992-09-15
All Time Low
0.06
All Time Low Change
756.9%
All Time Low Date
1998-09-01
ATR
0.01
Beta
0.64
Ch YTD
1.22
High
0.47
High52
0.59
High52 Date
2025-08-19
High52ch
-20.75%
Low
0.46
Low52
0.46
Low52 Date
2025-06-20
Low52ch
1.3%
Ma50ch
0.71%
Price vs 200-day SMA
-3.63%
RSI
31.05
RSI Monthly
40.23
RSI Weekly
30.57
Sharpe ratio
-0.4x
Sortino ratio
-0.21
Total Return
32.62%
Tr YTD
1.22
Tr15y
-21.91%
Tr1w
5.3%
Tr3m
-2.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
$110.8M
Operating Income Growth
-17.57
Operating Income Growth Q
-3.68
Operating Income Growth3 Y
8.89
Operating margin
5.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
295,837,724%
Net Borrowing
-8,642,742
Shares Insiders
11.15%
Shares Institutions
5.53%
Shares Qo Q
26.65%
Shares Yo Y
-0.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$91.3M
Average Volume
96,436.4x
Bv Per Share
4.56
CAPEX
$-33.2M
Ch10y
-71.89
Ch15y
-32.08
Ch1w
5.3
Ch1y
-2.36
Ch20y
70.91
Ch3m
-2.93
Ch3y
-29
Ch5y
11.19
Ch6m
-3.5
Change
-0.21%
Change From Open
1.08
Close
0.47
Days Gap
-1.28
Depreciation Amortization
74,598,218
Dollar Volume
22,521.8
Earnings Date
2026-04-29
EBIT
$110.8M
EBITDA
$185.4M
EPS
$0.07
F Score
5
FCF
$91.3M
FCF EV Yield
3.77x
Financing CF
-109,460,412
Fiscal Year End
December
Founded
1,990
Goodwill
243,848,737
Graham Number
0.22552
Graham Upside
-51.61
Income Tax
$31M
Investing CF
-200,288,834
Is Primary Listing
0
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2015-07-06
Last Split Type
Forward
Lynch Fair Value
$0.03
Lynch Upside
-93.56
Ma150
0.51
Ma150ch
-2.2%
Ma20
0.48
Ma20ch
2.56%
Net CF
-185,301,221
Next Earnings Date
2026-08-28
Open
0.46
P FCF Ratio
32.52
P OCF Ratio
23.84
Payment Date
2025-06-23
Position In Range
100
Ppne
1,014,009,079
Price Date
2026-05-08
Price EBITDA
$16.01
Ptbv Ratio
1.5
Relative Volume
0.5x
Revenue
1,952,370,316x
Tax By Revenue
1.59x
Tax Rate
43.79%
Tr20y
96.46%
Tr6m
-3.5%
Volume
48,330
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/900904 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+32.1%
$0.15 annual per share
Payout ratio
+230.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+37.0%
1 consecutive years of growth
Total shareholder yield
+32.6%
Next ex-dividend date: 2025-06-05
Performance

SHA/900904 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+1.7%
S&P 500 1Y: n/a
3Y total return
-21.8%
S&P 500 3Y: n/a
5Y total return
+25.4%
S&P 500 5Y: n/a
10Y total return
-67.8%
S&P 500 10Y: n/a
Ownership

Who owns SHA/900904?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.5%
Share of float held by funds and institutions
Insider ownership
+11.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.5%
Negative means the company is buying back shares.
Technical

SHA/900904 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
31.0
Neutral momentum band
Price vs 200-day MA
-3.6%
50/200-day relationship not available
Beta (5Y)
0.64
Less volatile than the market
Sharpe ratio
-0.40
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/900904

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/900904 stock rating?

sha/900904 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/900904 analysis?

The full report lives at /stocks/sha/900904/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/900904?

The latest report frames sha/900904 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/900904 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.